<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><title>Expert Angle with Dr. Frédéric Pouliot, presented in French</title><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:19.5pt;
font-family:"Helvetica","sans-serif";
color:#0067B1;
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:15.0pt;
font-family:"Helvetica","sans-serif";
color:#0067B1;
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Helvetica","sans-serif";
color:#0067B1;
font-weight:normal;}
h4
{mso-style-priority:9;
mso-style-link:"Heading 4 Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:10.5pt;
font-family:"Helvetica","sans-serif";
color:gray;
font-weight:normal;
font-style:italic;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading4Char
{mso-style-name:"Heading 4 Char";
mso-style-priority:9;
mso-style-link:"Heading 4";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;
font-style:italic;}
p.readmsgbody, li.readmsgbody, div.readmsgbody
{mso-style-name:readmsgbody;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.externalclass, li.externalclass, div.externalclass
{mso-style-name:externalclass;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcnimage, li.mcnimage, div.mcnimage
{mso-style-name:mcnimage;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.templatecolumn, li.templatecolumn, div.templatecolumn
{mso-style-name:templatecolumn;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcntextcontent, li.mcntextcontent, div.mcntextcontent
{mso-style-name:mcntextcontent;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.mcntextcontent1, li.mcntextcontent1, div.mcntextcontent1
{mso-style-name:mcntextcontent1;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:150%;
font-size:7.5pt;
font-family:"Helvetica","sans-serif";
color:gray;}
p.mcntextcontent2, li.mcntextcontent2, div.mcntextcontent2
{mso-style-name:mcntextcontent2;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:150%;
font-size:10.5pt;
font-family:"Helvetica","sans-serif";
color:#505050;}
p.mcntextcontent3, li.mcntextcontent3, div.mcntextcontent3
{mso-style-name:mcntextcontent3;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:110%;
font-size:10.5pt;
font-family:"Helvetica","sans-serif";
color:#505050;}
p.mcntextcontent4, li.mcntextcontent4, div.mcntextcontent4
{mso-style-name:mcntextcontent4;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:110%;
font-size:10.5pt;
font-family:"Helvetica","sans-serif";
color:#505050;}
p.mcntextcontent5, li.mcntextcontent5, div.mcntextcontent5
{mso-style-name:mcntextcontent5;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:150%;
font-size:10.5pt;
font-family:"Arial","sans-serif";
color:#505050;}
p.mcntextcontent6, li.mcntextcontent6, div.mcntextcontent6
{mso-style-name:mcntextcontent6;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:150%;
font-size:7.5pt;
font-family:"Arial","sans-serif";
color:gray;}
span.EmailStyle35
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:2033142490;
mso-list-template-ids:-1463012552;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1030" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body bgcolor=white lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>See below wrt a webinar in FRENCH.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Prostate Cancer Canada [mailto:pccmail=prostatecancer.ca@mail254.suw14.mcdlv.net] <b>On Behalf Of </b>Prostate Cancer Canada<br><b>Sent:</b> November 12, 2015 1:44 PM<br><br><b>Subject:</b> Expert Angle with Dr. Frédéric Pouliot, presented in French<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:white;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:15.0pt 15.0pt 15.0pt 15.0pt'><div align=center><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse;border:none'><tr><td valign=top style='border:solid #00AEEF 1.0pt;border-bottom:none;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=366 style='width:274.5pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 0cm 6.75pt 13.5pt'><p class=MsoNormal style='line-height:150%'><span style='font-size:7.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:gray'>Expert Angle – Interact with prostate cancer experts <o:p></o:p></span></p></td></tr></table><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=right width=197 style='width:147.75pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 0cm'><p class=MsoNormal style='line-height:150%'><span style='font-size:7.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:gray'><a href="http://us2.campaign-archive2.com/?u=381dca877e43c44046caa6dd1&id=581a2d23d5&e=b7e2b89435" target="_blank"><span style='color:#606060'>View this email in your browser</span></a><br><br><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='border-top:none;border-left:solid #00AEEF 1.0pt;border-bottom:none;border-right:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse' id=templateHeader><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" alt="" style='position:absolute;margin-left:0;margin-top:0;width:450pt;height:117pt;z-index:251658240;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:left;mso-position-horizontal-relative:text;mso-position-vertical-relative:line' o:allowoverlap="f">
<v:imagedata src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/410_Header.jpg" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width=600 height=156 src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/410_Header.jpg" align=left v:shapes="_x0000_s1026"><![endif]><o:p></o:p></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100% !important'><tr><td style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'></td><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;min-width: 600px;max-width: 600px'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 600px;max-width: 600px'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#F7EEEE;border-collapse:collapse;border:none;min-width: 100% !important'><tr><td valign=top style='border:solid #F11010 1.0pt;padding:13.5pt 13.5pt 13.5pt 13.5pt'><h2>This upcoming webinar is presented in French.<o:p></o:p></h2><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'><br>On November 17, Dr. Frédéric Pouliot will present his Expert Angle webinar, "Recurrent Prostate Cancer: Diagnostic and Therapeutic Opportunities in 2015". This webinar will be presented in French.<br><br>You will find information below including a registration link. Feel free to forward this email to others if you know anyone who may be interested. <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><h2 style='line-height:15.6pt'><!--[if gte vml 1]><v:shape id="_x0000_s1027" type="#_x0000_t75" alt="" style='position:absolute;margin-left:80.05pt;margin-top:0;width:131.25pt;height:131.25pt;z-index:251659264;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:right;mso-position-horizontal-relative:text;mso-position-vertical-relative:line' o:allowoverlap="f">
<v:imagedata src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/4e33fcd5-516b-42ea-b921-09d250c97ec3.png" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width=175 height=175 src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/4e33fcd5-516b-42ea-b921-09d250c97ec3.png" align=right v:shapes="_x0000_s1027"><![endif]>Inscrivez-vous au webinaire de Dr Frédéric Pouliot – Le cancer de la prostate récidivant : état des possibilités diagnostiques et thérapeutiques en 2015<o:p></o:p></h2><p class=MsoNormal style='line-height:110%'><span style='font-size:10.5pt;line-height:110%;font-family:"Helvetica","sans-serif";color:#505050'><br>Le mardi soir 17 novembre, de 19 heure à 20 heure HNE, nous vous invitons à participer à un webinaire de <em><span style='font-family:"Helvetica","sans-serif"'>L’Angle de l’expert</span></em> EN DIRECT, en compagnie de Dr Frédéric Pouliot. Au cours de cette présentation, vous apprendrez: <o:p></o:p></span></p><ul type=disc><li class=MsoNormal style='color:#505050;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:15.6pt;mso-list:l0 level1 lfo1'><span style='font-size:10.5pt;font-family:"Helvetica","sans-serif"'>Définir une récidive après le traitement du cancer de la prostate traité par radiothérapie, chirurgie ou castration chimique<o:p></o:p></span></li><li class=MsoNormal style='color:#505050;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:15.6pt;mso-list:l0 level1 lfo1'><span style='font-size:10.5pt;font-family:"Helvetica","sans-serif"'>Discuter des modalités d’imagerie utilisées en clinique pour dépister les sites de récidive du cancer de la prostate récidivant<o:p></o:p></span></li><li class=MsoNormal style='color:#505050;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:15.6pt;mso-list:l0 level1 lfo1'><span style='font-size:10.5pt;font-family:"Helvetica","sans-serif"'>Présenter les différents traitements pour le cancer de la prostate récidivant dans le bassin (récidive locale) ou ailleurs dans le corps (métastases)<o:p></o:p></span></li><li class=MsoNormal style='color:#505050;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:15.6pt;mso-list:l0 level1 lfo1'><span style='font-size:10.5pt;font-family:"Helvetica","sans-serif"'>Présenter les nouvelles avancées thérapeutiques dans le cancer de la prostate résistant à la castration.<o:p></o:p></span></li></ul></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border-radius: 5px'><tr><td valign=top style='padding:0cm 13.5pt 13.5pt 13.5pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#00AEEF;border-collapse:collapse;word-wrap: break-word !important'><tr><td style='padding:12.0pt 12.0pt 12.0pt 12.0pt'><p class=MsoNormal align=center style='text-align:center'><span style='font-family:"Arial","sans-serif"'><a href="http://prostatecancer.us2.list-manage1.com/track/click?u=381dca877e43c44046caa6dd1&id=3924b54bdd&e=b7e2b89435" target="_blank" title=Inscrivez-vous><b><span style='color:white;text-decoration:none'>Inscrivez-vous</span></b></a> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:150%'><strong><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'>Date : </span></strong><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'><a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=9e271851d7&e=b7e2b89435" target="_blank"><span style='color:#0067B1'>Le mardi soir 17 novembre</span></a> <br><strong><span style='font-family:"Helvetica","sans-serif"'>Heure :</span></strong> </span><strong><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#00AEEF'>de 19 h à 20 h HNE </span></strong><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'><br><strong><span style='font-family:"Helvetica","sans-serif"'>Conférencière : </span></strong>Dr Frédéric Pouliot<br><strong><span style='font-family:"Helvetica","sans-serif"'>Lieu : </span></strong>par Internet et téléphone<br></span><em><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'>Vous pouvez vérifier votre connexion Internet avant le début du webinaire L’Angle de l’expert en participant à une séance de test <a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=e58ee071d8&e=b7e2b89435" target="_blank"><span style='color:#0067B1'>ici</span></a>.</span></em><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:7.5pt 13.5pt 7.5pt 13.5pt'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none'><tr><td style='border:none;border-top:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><h2>Dr Frédéric Pouliot<o:p></o:p></h2><p class=MsoNormal style='line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'><br></span><!--[if gte vml 1]><v:shape id="_x0000_s1028" type="#_x0000_t75" alt="" style='position:absolute;margin-left:98.8pt;margin-top:0;width:150pt;height:150pt;z-index:251660288;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:right;mso-position-horizontal-relative:text;mso-position-vertical-relative:line' o:allowoverlap="f">
<v:imagedata src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/d77158fd-b960-4d90-a060-d7ed54fd66c8.jpg" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width=200 height=200 src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/d77158fd-b960-4d90-a060-d7ed54fd66c8.jpg" align=right v:shapes="_x0000_s1028"><![endif]><span style='font-size:10.5pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#505050'>Dr Pouliot a obtenu un diplôme de doctorat en médecine (Md) et un diplôme de doctorat en physiologie-endocrinologie (PhD) à l’Université Laval. Après avoir terminé une résidence en urologie (FRCSC), il a effectué un stage post-doctoral (Fellow) en imagerie moléculaire et uro-oncologie à l’Université de Los Angeles en Californie (UCLA). Depuis 2010, il est aujourd’hui clinicien uro-oncologue au Centre Hospitalier Universitaire de Québec (CHU de Québec). Il a aussi un poste de professeur-Adjoint au département de Chirurgie de l’Université Laval. Il a obtenu en 2014, le prix de l’étoile montante en cancer de la prostate décerné par Movember/Prostate Cancer Canada. Ses intérêts de recherche cliniques et précliniques regroupent la détection et caractérisation des cellules de cancers de la prostate résistants à la castration et de cancers métastatiques par imagerie moléculaire en utilisant des systèmes d'amplification de la transcription ou par tomographie par émission de positrons (TEP) avec des traceurs comme la fluoro-choline ou le fluoro-désoxyglucose. <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:7.5pt 13.5pt 7.5pt 13.5pt'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none'><tr><td style='border:none;border-top:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><h2><span style='font-size:10.0pt'>Veuillez vérifier dans notre <a href="http://prostatecancer.us2.list-manage2.com/track/click?u=381dca877e43c44046caa6dd1&id=07c5b028aa&e=b7e2b89435" target="_blank"><span style='color:#0067B1;font-weight:normal'>site Web</span></a> les mises à jour et l’information sur les prochains webinaires de L’Angle de l’expert. </span><o:p></o:p></h2></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:7.5pt 13.5pt 7.5pt 13.5pt'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none'><tr><td style='border:none;border-top:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='border-top:none;border-left:solid #00AEEF 1.0pt;border-bottom:none;border-right:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse' id=templateColumns><tr><td width="50%" valign=top style='width:50.0%;padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=293 style='width:219.75pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><h3><strong><span style='font-size:13.5pt;font-family:"Helvetica","sans-serif"'>Qu’est-ce qu’un webinaire de L’Angle de l’expert? </span></strong><o:p></o:p></h3></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt'><p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_s1029" type="#_x0000_t75" alt="" style='position:absolute;margin-left:0;margin-top:0;width:192.75pt;height:120pt;z-index:251661312;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:left;mso-position-horizontal-relative:text;mso-position-vertical-relative:line' o:allowoverlap="f">
<v:imagedata src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/gotomeeting_screen.jpg" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width=257 height=160 src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/gotomeeting_screen.jpg" align=left v:shapes="_x0000_s1029"><![endif]><o:p></o:p></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=293 style='width:219.75pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:110%'><span style='font-size:10.5pt;line-height:110%;font-family:"Helvetica","sans-serif";color:#505050'>Un webinaire est un outil en ligne qui permet à des personnes de toutes les régions canadiennes de participer à une rencontre en ligne et de discuter de sujets importants, de voir des diaporamas et d’échanger. Nous avons recours à un service appelé GoToMeeting pour organiser ces webinaires.<br><br>L’Angle de l’expert est un lieu d’échange d’information et d’idées dans le cadre d’une série de webinaires. Vous aurez l’occasion de vous renseigner sur un large éventail de sujets, de poser des questions et de communiquer directement avec des experts dans leur domaine respectif de compétences. <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></td><td width="50%" valign=top style='width:50.0%;padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=293 style='width:219.75pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:110%'><span style='font-size:10.5pt;line-height:110%;font-family:"Helvetica","sans-serif";color:#505050'>*Une fois votre inscription terminée, vous recevrez un courriel contenant tous les détails sur le mode de participation.<br><br>*Vous devrez télécharger le logiciel <em><span style='font-family:"Helvetica","sans-serif"'>GoToMeeting</span></em>, <strong><span style='font-family:"Helvetica","sans-serif"'>ce qui peut prendre quelques minutes</span></strong>.<br><br>*Vous pouvez regarder le webinaire de votre ordinateur personnel et ainsi voir la présentation, entendre la conférencière et poser des questions.<br><br>*Si vous n’avez pas accès à un ordinateur, vous pouvez tout de même participer en composant le 1-800 pour écouter la discussion.<br><br>*Seules les personnes qui ont accès à un ordinateur personnel pendant le webinaire pourront poser des questions.<br><br>*L’inscription ne garantit pas une place. Seules les 100 premières personnes à s’inscrire au webinaire pourront participer. Soyez à l’heure! <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='border-top:none;border-left:solid #00AEEF 1.0pt;border-bottom:none;border-right:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border-collapse:collapse' id=templateBody><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:7.5pt 13.5pt 7.5pt 13.5pt'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none'><tr><td style='border:none;border-top:solid #00AEEF 1.0pt;padding:0cm 0cm 0cm 0cm'></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center;line-height:150%'><strong><span style='font-size:10.5pt;line-height:150%;font-family:"Arial","sans-serif";color:#0067B1'>Initiative fièrement appuyée par un consortium de partenaires sectoriels</span></strong><span style='font-size:10.5pt;line-height:150%;font-family:"Arial","sans-serif";color:#505050'><br><img border=0 width=150 height=64 id="_x0000_i1025" src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/astellas.jpg"><img border=0 width=75 height=33 id="_x0000_i1026" src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/amgen.jpg"><img border=0 width=75 height=34 id="_x0000_i1027" src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/ferring.jpg"><img border=0 width=75 height=41 id="_x0000_i1028" src="https://gallery.mailchimp.com/381dca877e43c44046caa6dd1/images/janssen.jpg"><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr><tr><td valign=top style='border:solid #00AEEF 1.0pt;border-top:none;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:#EEEEEE;border-collapse:collapse' id=templateFooter><tr><td valign=top style='padding:0cm 0cm 6.75pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:110%'><strong><span style='font-size:9.0pt;line-height:110%;font-family:"Arial","sans-serif";color:gray'>Connect with us:</span></strong><span style='font-size:7.5pt;line-height:110%;font-family:"Arial","sans-serif";color:gray'> <o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:0cm 6.75pt 0cm 6.75pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#EEEEEE;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 6.75pt 0cm 6.75pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse'><tr><td valign=top style='padding:0cm 7.5pt 6.75pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse'><tr><td width=18 style='width:13.5pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancer.us2.list-manage1.com/track/click?u=381dca877e43c44046caa6dd1&id=39362ef831&e=b7e2b89435" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 id="_x0000_i1029" src="http://cdn-images.mailchimp.com/icons/social-block/color-facebook-128.png"></span></a><o:p></o:p></p></td><td style='padding:0cm 0cm 0cm 3.75pt'><p class=MsoNormal><a href="http://prostatecancer.us2.list-manage2.com/track/click?u=381dca877e43c44046caa6dd1&id=95b1ee4570&e=b7e2b89435"><span style='font-size:8.5pt;font-family:"Arial","sans-serif";color:#0067B1;text-decoration:none'>Facebook</span></a> <o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse'><tr><td valign=top style='padding:0cm 7.5pt 6.75pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse'><tr><td width=18 style='width:13.5pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=785c8532e9&e=b7e2b89435" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 id="_x0000_i1030" src="http://cdn-images.mailchimp.com/icons/social-block/color-twitter-128.png"></span></a><o:p></o:p></p></td><td style='padding:0cm 0cm 0cm 3.75pt'><p class=MsoNormal><a href="http://prostatecancer.us2.list-manage1.com/track/click?u=381dca877e43c44046caa6dd1&id=19ccfe6378&e=b7e2b89435"><span style='font-size:8.5pt;font-family:"Arial","sans-serif";color:#0067B1;text-decoration:none'>Twitter</span></a> <o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse'><tr><td valign=top style='padding:0cm 7.5pt 6.75pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse'><tr><td width=18 style='width:13.5pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancer.us2.list-manage1.com/track/click?u=381dca877e43c44046caa6dd1&id=635a083e5f&e=b7e2b89435" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 id="_x0000_i1031" src="http://cdn-images.mailchimp.com/icons/social-block/color-youtube-128.png"></span></a><o:p></o:p></p></td><td style='padding:0cm 0cm 0cm 3.75pt'><p class=MsoNormal><a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=7ed4039576&e=b7e2b89435"><span style='font-size:8.5pt;font-family:"Arial","sans-serif";color:#0067B1;text-decoration:none'>YouTube</span></a> <o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 6.75pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse'><tr><td width=18 style='width:13.5pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancer.us2.list-manage1.com/track/click?u=381dca877e43c44046caa6dd1&id=f5f0d8454d&e=b7e2b89435" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 id="_x0000_i1032" src="http://cdn-images.mailchimp.com/icons/social-block/color-instagram-128.png"></span></a><o:p></o:p></p></td><td style='padding:0cm 0cm 0cm 3.75pt'><p class=MsoNormal><a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=94b02c11eb&e=b7e2b89435"><span style='font-size:8.5pt;font-family:"Arial","sans-serif";color:#0067B1;text-decoration:none'>Instagram</span></a> <o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td><td valign=top style='padding:0cm 0cm 0cm 0cm'></td></tr></table></div></td></tr></table></div></td></tr></table></div></td></tr></table><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=600 style='width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:110%'><span style='font-size:8.5pt;line-height:110%;font-family:"Arial","sans-serif";color:gray'><a href="http://prostatecancer.us2.list-manage1.com/track/click?u=381dca877e43c44046caa6dd1&id=c8fbc66b9c&e=b7e2b89435" target="_blank"><span style='color:#606060'>Donate online</span></a> or call 1-888-255-0333 to make your gift.<br><br><a href="http://prostatecancer.us2.list-manage.com/profile?u=381dca877e43c44046caa6dd1&id=52f6bf5676&e=b7e2b89435"><span style='color:#606060'>Update subscription preferences</span></a> <a href="http://prostatecancer.us2.list-manage.com/unsubscribe?u=381dca877e43c44046caa6dd1&id=52f6bf5676&e=b7e2b89435&c=581a2d23d5"><span style='color:#606060'>Unsubscribe from this list</span></a> <a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=0923a41dd5&e=b7e2b89435" target="_self"><span style='color:#606060'>Privacy Policy</span></a><br><br><em><span style='font-family:"Arial","sans-serif"'>Copyright © 2015 Prostate Cancer Canada, All rights reserved.</span></em><br>PCCN has your email because you're a part of PCCN<br><br><br>Prostate Cancer Canada<br>2 Lombard St.<br>Toronto, ON<br>M5C 1M1<br><a href="http://prostatecancer.us2.list-manage.com/track/click?u=381dca877e43c44046caa6dd1&id=d2ec4e0d6d&e=b7e2b89435" target="_self"><span style='color:#606060'>prostatecancer.ca</span></a> <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr></table></div><p class=MsoNormal><img border=0 width=1 height=1 id="_x0000_i1033" src="http://prostatecancer.us2.list-manage.com/track/open.php?u=381dca877e43c44046caa6dd1&id=581a2d23d5&e=b7e2b89435"><o:p></o:p></p></div></body></html>